The aim of this study was to examine if extract of bifidobacteria, a major species of the human colonic microflora participates in the barrier effect against enteropathogens by developing antimicrobial activity against virulent bacteria. Six human bifidobacteria strains were isolated from infant stools. They were characterized and identified through physiological, biochemical tests and API 20 A test system. The isolates belonged to the three species: B. breve, B.longum and B.infantis. The cell extracts of the isolates were examined for antimicrobial activity by determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). For this purpose, the methicillin-resistant S. aureus (MRSA) was chosen as an indicator. MRSA treated with cell-free supernatants (CFS) from bifidobacteria were examined. All the Bifidobacterium isolates used have been identified as novel probiotics with a greater ability to survive at low pH and high concentrations of bile salt in vitro . 0.5 McFarland standard (10 8 CFU/ml) of a confirmed MRSA strain was challenged with the CFS strains by employing the tube dilution method and subculture on MRS agar assays. The cell-free supernatants of the 6 LAB strains exhibited MIC values between 50 µl/ml and 200 µl/ml. Only two CFS of bifidobacteria (b3 and b 4) had no MIC and MBC values with the concentrations under the current study. The b1, BL and BI strains showed highest antibacterial activity by MIC value with 100 conc. and by MBC value with 150 conc. Increased concentration levels of the cell-free extract (CFE) correlated with a decrease in MRSA viability. MRS broth medium (control) showed a high growth rate of MRSA without CFE.These results may provide a basis for alternative therapies for the treatment of MRSA superbug.
| Published in | American Journal of Biomedical and Life Sciences (Volume 4, Issue 5) |
| DOI | 10.11648/j.ajbls.20160405.12 |
| Page(s) | 75-80 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2016. Published by Science Publishing Group |
Bifidobacterium Spp., MBC, MIC, MRSA
| [1] | Senok, A. C., Ismaeel A. Y and Botta, G. A. (2005) Probiotics: facts and myths. Clinical microbiology and infection. Volume 11, Issue 12.Pages 958–966. |
| [2] | FAO/WHO. (2002). “Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food”. London, Ontario, Canada. |
| [3] | Mayo, B. (2010): Bifidobacteria: Genomics and molecular aspects (p. Xii 260). Norfolk, UK: Caister Academic. |
| [4] | Sagar, S., Morgan, M., Chen, S., Vos, A., Garssen, J., Bergenhenegouwen, J.,... Folkerts, G. (2014): Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma. Respiratory Research Respir Res, 15(1), 46-46. doi:10.1186/1465-9921-15-46. |
| [5] | Bamidelea T. A., Adeniyib B. A.,. Ayenib F. A., Foworaa M. A. and Smitha S.I. (2013). The antagonistic activities of Lactic acid bacteria isolated from Nigerian salad vegetables against methicillin resistant Staphylococcus aureus. Global Research Journal of Microbiology Vol. 3(1) pp.18–23. |
| [6] | Wysocki B. K, Bazo M, Smoragiewicz W. )2010(.“Antibacterial activity of Lactobacillus acidophilus andLactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). |
| [7] | Georgievaa R, Yochevab L, Tserovskab L, Zhelezovab G, Stefanovaa N, Atanasovaa A, and et al (2015). Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures. Biotechnology & Biotechnological Equipment, Vol. 29, No. 1, 8491. |
| [8] | Lee J S, Chung M J and Seo J G. (2013). In Vitro Evaluation of Antimicrobial Activity of Lactic Acid Bacteria against Clostridium difficile. Toxicol. Res. Vol. 29, No. 2, pp.99-106. |
| [9] | Antibiotic resistance: Skin infection prevention treatment helps battle 'superbugs' Written by Hannah Nichols Published: Sunday 31 July 2016 http://www.medicalnewstoday.com/articles/312008.php. |
| [10] | AL-Saadi, Z. N. (2010). “Study of ability of Lactobacillus acidophilus and Bifidobacterium bifidum in the prevention and treatment for enteritis induced by Salmonella typhimurium in Rats. Ph.D. thesis”. College of Education. Tikrit University. |
| [11] | Buchanan R. E. and Gibbons S. E. (1974). Berge’s Manual of Determinative Bcteriology.8th ed. Williams and Wilkins. Baltimore Maryland, USA. |
| [12] | Buck LM, Gilliland SE (1994). Comparison of freshly isolated strains of Lactobacillus acidophillus of human intestinal origin for ability to assimilate cholesterol during growth. J. Dairy Sci., 77: 2925–2933. |
| [13] | Fuller R. (1989). “Probiotics in man and animals”. J Appl Bacteriol 66(5): 365-378. |
| [14] | Harrigan, W. F and McCance, M. E. (1976). Laboratory Methods in Food and Dairy Microbiology, second ed. Academic Press, London. |
| [15] | Clinical and Laboratory Standards Institute (2010): Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, M100-S20. |
| [16] | Alzubaid Zainab M. Alzubaidy. Shean I. Kakey Jassim F. Ali (2013) Antibacterial Effects of Lactic Acid Bacteria Cell Free Extract on the Growth of Local Isolates of Listeria moncytogenes from some Food Sources. |
| [17] | Wasilewska E. and Bielecka M. (2003). ISOLATION AND IDENTIFICATION OF BIFIDOBACTERIA FROM INFANT GUT. Pol. J. Food Nutr. Sci. Vol. 12/53, SI 1, pp. 90–94. |
| [18] | Rita Narayanan, B.Suresh Subramonian, T. R. Pugazhenthi. (2013). “Isolation of Bifidobacteria from Infant Faeces Vol (3), 2250-1991. |
| [19] | Mikkel Jungersen, Anette Wind, Eric Johansen, Jeffrey E. Christensen, Birgitte Stuer-Lauridsen, and Dorte Eskesen (2014). The Science behind the Probiotic Strain Bifidobacterium animalis subsp. Lactis, 92-110; doi: 10.3390. |
| [20] | Kawasaki, S., T. Mimura, T. Satoh, K. Takeda, and Y. Niimura. (2006). “Response of the microaerophilic Bifidobacterium species”, B. boum and B. thermophilum, to oxygen. Appl. Environ. Microbiol. 72:6854-6858. |
| [21] | Zinedine A. and Faid M. (2007). Isolation and Characterization of Strains of Bifidobacteria with Probiotic Proprieties In vitro. World Journal of Dairy & Food Sciences 2 (1): 28-34. |
| [22] | Kail A Kail Asapathy and James Chin, (2007). “Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp., 78, 80–88. |
| [23] | Borja Sa´nchez, Marie-Christine Champomier-Verge` Mar´ıa del Carmen Collado,et al., (2007 ) Low-pH Adaptation and the Acid Tolerance Response of Bifidobacterium longum Biotype longum. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Vol. 73, No. 20, p. 6450–6459. |
| [24] | Amin M, Sheikh A.F., Goodarzi H. and Sormeh M. (2013). Identification of Bifidobacterium animalis, Bifidobacterium adolescentis and Bifidobacterium bifidum from Stool of Children and Detection of Their Antibacterial Properties. Advances in Infectious Diseases, 3, 200-204. |
| [25] | Denkova, R. V. Yanakieva, Z. Denkova, V. Nikolova & V. Radeva, (2013). In vitro inhibitory activity of Bifidobacterium and Lactobacillus strains against Candida albicans. Bulg. J. Vet. Med., 16, No 3, 186−197. |
| [26] | Mohsen, Y. M. B., Shawket, D. S. and Abd-Alsattar,D. (2013). NOVEL PROBIOTIC BIFIDOBACTERIUM OVERCOMES SYNERGISTIC EFFECT OF THREE NATURALBIOTIC OMNI DRUG AND ANTIBIOTIC AGAINST SOME UTI PATHOGENS. I.J.S.N., VOL. 4(3):456-462. |
| [27] | Chenoll E., Casinos B., Bataller E., Astals P., Echevarría J., Iglesias J. R., et al. (2011). Novel probioticBifidobacterium bifidum CECT 7366 strain active against the pathogenic bacterium Helicobacter pylori. Appl. Environ. Microbiol. 77 1335–1343. 10.1128. |
| [28] | Hor, Y. Y. and Liong, M. T.(2014). Use of extracellular extracts of lactic acid bacteria and bifidobacteria for the inhibition of dermatological pathogen Staphylococcus aureus. Dermatologica Sinica. 32: 141-147. |
| [29] | Hentges DJ, Marsh WW, Petschow BW,et al (1995). Influence of a human milk diet on colonization resistance mechanisms against Salmonella typhimurium in human faecal bacteriaassociated mice. Microb Ecol Health Dis; 8: 139–49. |
| [30] | Gibson GR,Wang W.(1994).Regulatory effects of bifidobacteria on the growth of other colonic bacteria.J Appl Bacteriol; 77:412–20 |
| [31] | Bernet M-F, Brassart D, Neeser JR, et al. (1993). Adhering bifidobacterial strains inhibit interactions of enteropathogens with cultured human intestinal epithelial cells. Appl Environ Microbiol; 59: 4121–8. |
| [32] | Liévin V, PeiVer I, Hudault S, Rochat F, Brassart D, Neeser J-R, Servin A L (200 ) Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut;47:646–652646. |
APA Style
Zainab Nashaat AL-Saadi`. (2016). Estimation of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Cell-Free Extracts of Bifidobacterium Species Against Methicillin-Resistant Staphylococcus aureus in vitro. American Journal of Biomedical and Life Sciences, 4(5), 75-80. https://doi.org/10.11648/j.ajbls.20160405.12
ACS Style
Zainab Nashaat AL-Saadi`. Estimation of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Cell-Free Extracts of Bifidobacterium Species Against Methicillin-Resistant Staphylococcus aureus in vitro. Am. J. Biomed. Life Sci. 2016, 4(5), 75-80. doi: 10.11648/j.ajbls.20160405.12
AMA Style
Zainab Nashaat AL-Saadi`. Estimation of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Cell-Free Extracts of Bifidobacterium Species Against Methicillin-Resistant Staphylococcus aureus in vitro. Am J Biomed Life Sci. 2016;4(5):75-80. doi: 10.11648/j.ajbls.20160405.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajbls.20160405.12,
author = {Zainab Nashaat AL-Saadi`},
title = {Estimation of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Cell-Free Extracts of Bifidobacterium Species Against Methicillin-Resistant Staphylococcus aureus in vitro},
journal = {American Journal of Biomedical and Life Sciences},
volume = {4},
number = {5},
pages = {75-80},
doi = {10.11648/j.ajbls.20160405.12},
url = {https://doi.org/10.11648/j.ajbls.20160405.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbls.20160405.12},
abstract = {The aim of this study was to examine if extract of bifidobacteria, a major species of the human colonic microflora participates in the barrier effect against enteropathogens by developing antimicrobial activity against virulent bacteria. Six human bifidobacteria strains were isolated from infant stools. They were characterized and identified through physiological, biochemical tests and API 20 A test system. The isolates belonged to the three species: B. breve, B.longum and B.infantis. The cell extracts of the isolates were examined for antimicrobial activity by determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). For this purpose, the methicillin-resistant S. aureus (MRSA) was chosen as an indicator. MRSA treated with cell-free supernatants (CFS) from bifidobacteria were examined. All the Bifidobacterium isolates used have been identified as novel probiotics with a greater ability to survive at low pH and high concentrations of bile salt in vitro . 0.5 McFarland standard (10 8 CFU/ml) of a confirmed MRSA strain was challenged with the CFS strains by employing the tube dilution method and subculture on MRS agar assays. The cell-free supernatants of the 6 LAB strains exhibited MIC values between 50 µl/ml and 200 µl/ml. Only two CFS of bifidobacteria (b3 and b 4) had no MIC and MBC values with the concentrations under the current study. The b1, BL and BI strains showed highest antibacterial activity by MIC value with 100 conc. and by MBC value with 150 conc. Increased concentration levels of the cell-free extract (CFE) correlated with a decrease in MRSA viability. MRS broth medium (control) showed a high growth rate of MRSA without CFE.These results may provide a basis for alternative therapies for the treatment of MRSA superbug.},
year = {2016}
}
TY - JOUR T1 - Estimation of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of Cell-Free Extracts of Bifidobacterium Species Against Methicillin-Resistant Staphylococcus aureus in vitro AU - Zainab Nashaat AL-Saadi` Y1 - 2016/10/31 PY - 2016 N1 - https://doi.org/10.11648/j.ajbls.20160405.12 DO - 10.11648/j.ajbls.20160405.12 T2 - American Journal of Biomedical and Life Sciences JF - American Journal of Biomedical and Life Sciences JO - American Journal of Biomedical and Life Sciences SP - 75 EP - 80 PB - Science Publishing Group SN - 2330-880X UR - https://doi.org/10.11648/j.ajbls.20160405.12 AB - The aim of this study was to examine if extract of bifidobacteria, a major species of the human colonic microflora participates in the barrier effect against enteropathogens by developing antimicrobial activity against virulent bacteria. Six human bifidobacteria strains were isolated from infant stools. They were characterized and identified through physiological, biochemical tests and API 20 A test system. The isolates belonged to the three species: B. breve, B.longum and B.infantis. The cell extracts of the isolates were examined for antimicrobial activity by determination of minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). For this purpose, the methicillin-resistant S. aureus (MRSA) was chosen as an indicator. MRSA treated with cell-free supernatants (CFS) from bifidobacteria were examined. All the Bifidobacterium isolates used have been identified as novel probiotics with a greater ability to survive at low pH and high concentrations of bile salt in vitro . 0.5 McFarland standard (10 8 CFU/ml) of a confirmed MRSA strain was challenged with the CFS strains by employing the tube dilution method and subculture on MRS agar assays. The cell-free supernatants of the 6 LAB strains exhibited MIC values between 50 µl/ml and 200 µl/ml. Only two CFS of bifidobacteria (b3 and b 4) had no MIC and MBC values with the concentrations under the current study. The b1, BL and BI strains showed highest antibacterial activity by MIC value with 100 conc. and by MBC value with 150 conc. Increased concentration levels of the cell-free extract (CFE) correlated with a decrease in MRSA viability. MRS broth medium (control) showed a high growth rate of MRSA without CFE.These results may provide a basis for alternative therapies for the treatment of MRSA superbug. VL - 4 IS - 5 ER -
Email: